Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFatigue is one of the most commonly reported side effects during tirzepatide treatment, and clinical trial data backs up what many people experience in those first weeks. In SURMOUNT-1, published in the New England Journal of Medicine, fatigue was recorded among the adverse events in the active treatment arms, typically presenting early and settling as the body adjusted. If you're experiencing low energy on Mounjaro, you're not imagining it — but understanding why it happens, and what usually resolves it, makes a real difference to how you manage those early weeks.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
SURMOUNT-1 enrolled 2,539 adults across three active dose arms, and fatigue appeared consistently in the adverse-event reporting — not as a dramatic outlier, but as a recognised pattern. The mechanism makes biological sense. Tirzepatide activates both GIP and GLP-1 receptors, slowing gastric emptying and reducing appetite significantly. When the body moves from its usual caloric input to a lower intake fairly quickly, energy levels often reflect that shift before they stabilise. This isn't a sign that something has gone wrong; it's the system adjusting.
Dose increases are where most people notice the dip most sharply. The starter dose is designed primarily for tolerability, giving your system time to adapt before stepping up. Each increase can briefly replay that adjustment period, including the tiredness. Many people find the fatigue on Mounjaro is largely front-loaded, heaviest in the first week or two after a new dose, then gradually fading. If you want a fuller picture of the trial evidence behind tirzepatide's effects, our tirzepatide overview covers the key findings.
One thing worth separating out: the fatigue that comes with rapid weight loss itself is distinct from the direct pharmacological effect. Both can overlap, especially in the first month. If you are trying to understand exactly why lack of energy on Mounjaro happens, that page breaks down the overlapping causes in more detail. The body is doing a lot of work (redistributing energy stores, adapting hormone signalling) and that costs something in terms of how alert and energetic you feel day to day.
Low energy on Mounjaro usually has more than one driver, and some are more actionable than others. The most common ones our prescribers hear about fall into a few clear categories.
Protein and calorie intake. Tirzepatide reduces appetite substantially, which is the point, but eating very little, or letting protein fall too low, compounds fatigue. Muscle relies on adequate protein to maintain itself during weight loss, and when intake drops sharply the body can feel genuinely depleted. Aiming for regular, protein-led meals (even small ones) tends to make a measurable difference to energy levels. A registered dietitian can help you work out what adequate looks like for your weight at each stage.
Hydration. Nausea and reduced thirst can both lead to drinking less, and mild dehydration is a surprisingly effective way to feel exhausted. Keeping fluid intake steady, especially through any gastrointestinal side effects, helps more than people expect. There is useful practical guidance on maintaining a healthy diet alongside treatment on the weight-loss treatment overview.
Sleep disruption. Some people find that the GI effects of early treatment (including reflux or needing to wake at night) quietly undercut sleep quality. Fixing the downstream issue (position after eating, timing of the last meal) can restore more energy than any direct intervention. Our frequently asked questions include several practical queries about managing early side effects.
Iron and B12. If fatigue persists well past the adjustment window, it is worth asking your GP to check for nutritional deficiencies. Eating less food over months can reduce micronutrient intake even when macros look adequate. This is a conversation for your prescriber or GP, not a reason to self-supplement without advice.
Most fatigue on tirzepatide is expected and self-limiting. Some patterns are worth escalating. If tiredness arrives with severe stomach pain (especially pain that radiates through to the back) that is a symptom the MHRA Drug Safety Updates flag as potentially indicating acute pancreatitis, which requires urgent medical assessment. This is rare, but it is serious. Similarly, fatigue paired with signs of significant dehydration (dizziness, very dark urine, inability to keep fluids down) should be treated as a reason to contact a healthcare professional the same day, not something to wait out.
Fatigue that shows no sign of improving after two to three weeks at a stable dose, or that worsens after the initial adjustment, is also worth raising. Our clinical team at nume (sorry, at nume) reviews every repeat order before dispatch, which is one of the moments to flag concerns if they haven't already been raised. Some people find it useful to read about having no energy on Mounjaro alongside this page, as that covers more acute presentations.
For anyone wondering whether Mounjaro can give you energy as treatment progresses, yes, it can for some people, and there is a separate page covering whether Mounjaro can eventually improve energy for some people, which is a different but related question worth understanding.
If you are already on tirzepatide and feeling persistently drained, the most useful first step is a conversation with your prescriber, not a forum, not a search engine. The prescriber can look at your dose timing, your pattern of side effects and your overall picture before making any recommendations about whether to slow the titration schedule, adjust anything else, or simply reassure you that what you're experiencing is on track.
Prescription-only medicines like Mounjaro require that kind of clinical oversight by design. The NHS tirzepatide medicines page lists fatigue explicitly alongside other common side effects and is worth bookmarking as a reference. Questions about a specific symptom combination (for example, wondering whether managing constipation alongside fatigue affects anything) are exactly the kind of thing a prescriber can answer properly in context. And if you're still at the stage of considering whether tirzepatide is the right treatment for you, our free consultation is the place to start that conversation with a GPhC-registered prescriber who reviews every application the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.